SR-0379
Skin Ulcers
Phase 3Active
Key Facts
About FunPep
Japanese biotech developing functional peptides for skin ulcers and antibody-inducing vaccines, with a Phase III candidate showing angiogenesis and antimicrobial activity.
View full company profile